Comparing two drugs for whipworm infection
Treatments studied
Part of Infections clinical trials.
This trial tests a new drug, emodepside, against the standard treatment albendazole for whipworm infection. It aims to see which is safer and works better in adolescents and adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have a whipworm infection confirmed by a stool test with at least 48 eggs per gram.
- You are willing to provide two stool samples at the start and again 2-3 weeks after treatment.
- You agree to be examined by a study doctor before treatment.
- You have not taken any deworming medication in the last 4 weeks.
- You are not pregnant or breastfeeding and have no major health issues like severe anemia or fever.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether oxfendazole can better treat whipworm (Trichuris trichiura) in adults by checking stool samples before and after treatment. You may be eligible if you’ve recently had whipworm found in stool and can return for multiple follow-up samples.
This study tests a new medicine called emodepside to treat infections caused by intestinal worms like whipworm, hookworm, and roundworm. It may help people who have not been cured by standard treatments.
This study tests new combinations of deworming medicines to treat whipworm infection in school-aged children in Honduras. It aims to find a more effective treatment for children with this parasitic infection.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
This Phase 1 trial tests how safe and tolerated orally taken Trichuris trichiura (a type of intestinal worm) eggs are in healthy adults. It aims to help researchers understand early safety and study setup before any future treatments.
This trial tests a new chewable tablet (ZP5-9676) to treat common intestinal worm infections. It compares the new drug to a placebo (fake pill) to see if it's safe and effective.
Hear when a new Trichuris Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.